Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, noviembre 06
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Inventiva SA
IVA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$3.77
0.14
3.72%
Últ. Act.: Nov 6, 12:25 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Comparar
Opciones
Informe de acciones
Inventiva Analyst Price Targets - Benzinga
Inventiva Analyst Price Targets
Wall Street analyst price targets and consensus rating for Inventiva (IVA).
Analyst Ratings News
PRO
HC Wainwright & Co. Maintains Buy on Inventiva, Lowers Price Target to $14
HC Wainwright & Co. analyst Ananda Ghosh maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the price target from $24 to $14.
Benzinga Newsdesk
PRO
Truist Securities Maintains Buy on Inventiva, Raises Price Target to $18
Truist Securities analyst Srikripa Devarakonda maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $13 to $18.
Benzinga Newsdesk
PRO
Canaccord Genuity Maintains Buy on Inventiva, Raises Price Target to $21
Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $20 to $21.
Benzinga Newsdesk
PRO
Guggenheim Maintains Buy on Inventiva, Raises Price Target to $14
Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $11 to $14.
Benzinga Newsdesk
PRO
Cantor Fitzgerald Initiates Coverage On Inventiva with Overweight Rating
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating.
Benzinga Newsdesk
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy rating, $88 PT. See analyst ratings.
Avi Kapoor
Crear lista de seguimiento
GRATIS: Haz un seguimiento de acciones y criptomonedas con las mejores alertas de Internet
Haz clic para comenzar
People Also Watch
AbbVie Inc
NYSE:ABBV
$289.64
0.49%
Amgen Inc
NASDAQ:AMGN
$460.17
-0.02%
Gilead Sciences Inc
NASDAQ:GILD
$167.86
0.17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$547.13
0.85%
Moderna Inc
NASDAQ:MRNA
$263.08
8.95%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$905.73
0.31%
argenx SE
NASDAQ:ARGX
$922.1
3.05%
BeOne Medicines Ltd
NASDAQ:ONC
$407.99
5.35%
Natera Inc
NASDAQ:NTRA
$315.79
-13.19%
Revolution Medicines Inc
NASDAQ:RVMD
$192.17
8.17%
Muestra todas las empresas relacionadas con 10
